D
Daniel Moon
Researcher at Peter MacCallum Cancer Centre
Publications - 107
Citations - 2369
Daniel Moon is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 23, co-authored 80 publications receiving 1703 citations. Previous affiliations of Daniel Moon include Monash University, Clayton campus & Royal Melbourne Hospital.
Papers
More filters
Journal ArticleDOI
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Shankar Siva,Shankar Siva,Mathias Bressel,Declan G. Murphy,Mark Shaw,Sarat Chander,John Violet,Keen Hun Tai,Cristian Udovicich,Andrew Lim,Lisa Selbie,Michael S Hofman,Michael S Hofman,Tomas Kron,Tomas Kron,Daniel Moon,Jeremy Goad,Nathan Lawrentschuk,Nathan Lawrentschuk,Farshad Foroudi +19 more
TL;DR: A single SABR session was feasible and associated with low morbidity in this cohort and was found to be safe with avoidance of hormone therapy in almost half of the participants at 2 yr.
Journal ArticleDOI
Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?
Jeremy Grummet,Mahesha Weerakoon,Sean Huang,Nathan Lawrentschuk,Mark Frydenberg,Daniel Moon,Mary O'Reilly,Declan G. Murphy +7 more
TL;DR: To determine the rate of hospital re‐admission for sepsis after transperineal (TP) biopsy using both local data and worldwide literature, as there is growing interest in TP biopsy as an alternative to transrectal ultrasonography (TRUS)‐guided biopsy for patients undergoing repeat prostate biopsy.
Journal ArticleDOI
Laparoscopic pyeloplasty: Evolution of a new gold standard
TL;DR: The results are consistent with previous series and support the view that laparoscopic pyeloplasty is moving rapidly toward replacing open surgery as the gold standard in the treatment of ureteropelvic junction obstruction.
Journal ArticleDOI
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study
Louise Emmett,Louise Emmett,James Buteau,Nathan Papa,Daniel Moon,James Thompson,Matthew J. Roberts,Kris Rasiah,David A. Pattison,John Yaxley,Paul Thomas,Anthony C. Hutton,Shikha Agrawal,Amer Amin,Alexandar Blazevski,Venu Chalasani,Bao Ho,Andrew Nguyen,Victor Liu,Jonathan Lee,Gemma Sheehan-Dare,Raji Kooner,Geoff Coughlin,Lyn Chan,Thomas Cusick,Benjamin Namdarian,Jada Kapoor,Omar Alghazo,Henry H. Woo,Nathan Lawrentschuk,Declan G. Murphy,Michael S Hofman,Phillip D. Stricker +32 more
TL;DR: In this article, a prospective multicentre phase II imaging trial was conducted to determine whether the combination of PSMA+MRI was superior to MRI in diagnostic performance for detecting clinically significant prostate cancer (csPCa).
Journal ArticleDOI
Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol 2017;71:353–65
TL;DR: The time is nigh to abandon the transrectal approach to prostate biopsy, and transperineal biopsy represents a clean alternative, with minimal infection risk and no need for quinolones, let alone other broader spectrum antibiotics.